nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—mammary gland—sarcoma	0.0357	0.182	CbGeAlD
Sodium stibogluconate—TOP1—myometrium—sarcoma	0.0253	0.129	CbGeAlD
Sodium stibogluconate—TOP1—seminal vesicle—sarcoma	0.0229	0.117	CbGeAlD
Sodium stibogluconate—TOP1—smooth muscle tissue—sarcoma	0.0191	0.0976	CbGeAlD
Sodium stibogluconate—TOP1—cardiac atrium—sarcoma	0.0165	0.0842	CbGeAlD
Sodium stibogluconate—TOP1—uterus—sarcoma	0.0164	0.0837	CbGeAlD
Sodium stibogluconate—TOP1—tendon—sarcoma	0.0144	0.0734	CbGeAlD
Sodium stibogluconate—TOP1—bone marrow—sarcoma	0.0139	0.0711	CbGeAlD
Sodium stibogluconate—TOP1—testis—sarcoma	0.0119	0.0607	CbGeAlD
Sodium stibogluconate—TOP1—liver—sarcoma	0.0113	0.0574	CbGeAlD
Sodium stibogluconate—TOP1—lymph node—sarcoma	0.00863	0.044	CbGeAlD
Sodium stibogluconate—Extravasation—Epirubicin—sarcoma	0.00306	0.0038	CcSEcCtD
Sodium stibogluconate—Dysphagia—Etoposide—sarcoma	0.00298	0.00371	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Thiotepa—sarcoma	0.00297	0.00369	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Etoposide—sarcoma	0.00293	0.00365	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Vincristine—sarcoma	0.00293	0.00365	CcSEcCtD
Sodium stibogluconate—Cellulitis—Epirubicin—sarcoma	0.00293	0.00365	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Epirubicin—sarcoma	0.00291	0.00362	CcSEcCtD
Sodium stibogluconate—Sweating increased—Etoposide—sarcoma	0.00291	0.00362	CcSEcCtD
Sodium stibogluconate—Oliguria—Epirubicin—sarcoma	0.00289	0.0036	CcSEcCtD
Sodium stibogluconate—Extravasation—Doxorubicin—sarcoma	0.00283	0.00352	CcSEcCtD
Sodium stibogluconate—Ulcer—Epirubicin—sarcoma	0.00282	0.00351	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Epirubicin—sarcoma	0.0028	0.00348	CcSEcCtD
Sodium stibogluconate—Vision blurred—Thiotepa—sarcoma	0.00273	0.00339	CcSEcCtD
Sodium stibogluconate—Cellulitis—Doxorubicin—sarcoma	0.00271	0.00337	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Doxorubicin—sarcoma	0.00269	0.00335	CcSEcCtD
Sodium stibogluconate—Oliguria—Doxorubicin—sarcoma	0.00268	0.00333	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Etoposide—sarcoma	0.00262	0.00326	CcSEcCtD
Sodium stibogluconate—Renal failure—Etoposide—sarcoma	0.00262	0.00325	CcSEcCtD
Sodium stibogluconate—Ulcer—Doxorubicin—sarcoma	0.00261	0.00324	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Etoposide—sarcoma	0.00261	0.00324	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Doxorubicin—sarcoma	0.00259	0.00322	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Mitoxantrone—sarcoma	0.00256	0.00319	CcSEcCtD
Sodium stibogluconate—Fluid retention—Epirubicin—sarcoma	0.00253	0.00315	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Epirubicin—sarcoma	0.00252	0.00313	CcSEcCtD
Sodium stibogluconate—Convulsion—Thiotepa—sarcoma	0.00251	0.00312	CcSEcCtD
Sodium stibogluconate—Anxiety—Thiotepa—sarcoma	0.00246	0.00305	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Mitoxantrone—sarcoma	0.00245	0.00304	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Etoposide—sarcoma	0.00238	0.00296	CcSEcCtD
Sodium stibogluconate—Vision blurred—Mitoxantrone—sarcoma	0.00236	0.00293	CcSEcCtD
Sodium stibogluconate—Infection—Thiotepa—sarcoma	0.00235	0.00292	CcSEcCtD
Sodium stibogluconate—Oedema—Dactinomycin—sarcoma	0.00234	0.00292	CcSEcCtD
Sodium stibogluconate—Fluid retention—Doxorubicin—sarcoma	0.00234	0.00291	CcSEcCtD
Sodium stibogluconate—Infection—Dactinomycin—sarcoma	0.00233	0.0029	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Doxorubicin—sarcoma	0.00233	0.0029	CcSEcCtD
Sodium stibogluconate—Sepsis—Epirubicin—sarcoma	0.00231	0.00288	CcSEcCtD
Sodium stibogluconate—Tachycardia—Thiotepa—sarcoma	0.00231	0.00287	CcSEcCtD
Sodium stibogluconate—Anorexia—Thiotepa—sarcoma	0.00225	0.0028	CcSEcCtD
Sodium stibogluconate—Phlebitis—Epirubicin—sarcoma	0.00225	0.00279	CcSEcCtD
Sodium stibogluconate—Anorexia—Dactinomycin—sarcoma	0.00223	0.00278	CcSEcCtD
Sodium stibogluconate—Convulsion—Vincristine—sarcoma	0.00222	0.00277	CcSEcCtD
Sodium stibogluconate—Convulsion—Mitoxantrone—sarcoma	0.00217	0.00269	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—sarcoma	0.00214	0.00266	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—sarcoma	0.00213	0.00265	CcSEcCtD
Sodium stibogluconate—Chest pain—Mitoxantrone—sarcoma	0.00213	0.00265	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Thiotepa—sarcoma	0.00212	0.00264	CcSEcCtD
Sodium stibogluconate—Anxiety—Mitoxantrone—sarcoma	0.00212	0.00264	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Epirubicin—sarcoma	0.0021	0.00261	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Vincristine—sarcoma	0.00209	0.00261	CcSEcCtD
Sodium stibogluconate—Oedema—Vincristine—sarcoma	0.00209	0.00261	CcSEcCtD
Sodium stibogluconate—Infection—Vincristine—sarcoma	0.00208	0.00259	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—sarcoma	0.00208	0.00259	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Thiotepa—sarcoma	0.00205	0.00255	CcSEcCtD
Sodium stibogluconate—Oedema—Mitoxantrone—sarcoma	0.00204	0.00254	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Mitoxantrone—sarcoma	0.00204	0.00254	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Dactinomycin—sarcoma	0.00204	0.00253	CcSEcCtD
Sodium stibogluconate—Fatigue—Thiotepa—sarcoma	0.00204	0.00253	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Etoposide—sarcoma	0.00204	0.00253	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—sarcoma	0.00203	0.00253	CcSEcCtD
Sodium stibogluconate—Infection—Mitoxantrone—sarcoma	0.00203	0.00252	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Vincristine—sarcoma	0.00202	0.00252	CcSEcCtD
Sodium stibogluconate—Fatigue—Dactinomycin—sarcoma	0.00202	0.00251	CcSEcCtD
Sodium stibogluconate—Constipation—Thiotepa—sarcoma	0.00202	0.00251	CcSEcCtD
Sodium stibogluconate—Shock—Mitoxantrone—sarcoma	0.00201	0.0025	CcSEcCtD
Sodium stibogluconate—Anorexia—Vincristine—sarcoma	0.002	0.00248	CcSEcCtD
Sodium stibogluconate—Tachycardia—Mitoxantrone—sarcoma	0.00199	0.00248	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—sarcoma	0.00197	0.00246	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—sarcoma	0.00197	0.00246	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Mitoxantrone—sarcoma	0.00197	0.00245	CcSEcCtD
Sodium stibogluconate—Hypotension—Vincristine—sarcoma	0.00196	0.00243	CcSEcCtD
Sodium stibogluconate—Anorexia—Mitoxantrone—sarcoma	0.00194	0.00242	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—sarcoma	0.00194	0.00242	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—sarcoma	0.00194	0.00241	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Thiotepa—sarcoma	0.00193	0.0024	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Dactinomycin—sarcoma	0.00192	0.00238	CcSEcCtD
Sodium stibogluconate—Hypotension—Mitoxantrone—sarcoma	0.00191	0.00237	CcSEcCtD
Sodium stibogluconate—Renal impairment—Doxorubicin—sarcoma	0.00188	0.00234	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Vincristine—sarcoma	0.00188	0.00234	CcSEcCtD
Sodium stibogluconate—Urticaria—Thiotepa—sarcoma	0.00188	0.00233	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Thiotepa—sarcoma	0.00187	0.00232	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Thiotepa—sarcoma	0.00187	0.00232	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Dactinomycin—sarcoma	0.00185	0.00231	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Dactinomycin—sarcoma	0.00185	0.00231	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Mitoxantrone—sarcoma	0.00183	0.00228	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Etoposide—sarcoma	0.00183	0.00227	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—sarcoma	0.00183	0.00227	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Vincristine—sarcoma	0.00182	0.00226	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Mitoxantrone—sarcoma	0.00182	0.00226	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—sarcoma	0.00181	0.00225	CcSEcCtD
Sodium stibogluconate—Fatigue—Vincristine—sarcoma	0.00181	0.00225	CcSEcCtD
Sodium stibogluconate—Convulsion—Etoposide—sarcoma	0.0018	0.00224	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—sarcoma	0.0018	0.00224	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—sarcoma	0.0018	0.00224	CcSEcCtD
Sodium stibogluconate—Constipation—Vincristine—sarcoma	0.00179	0.00223	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Mitoxantrone—sarcoma	0.00177	0.00221	CcSEcCtD
Sodium stibogluconate—Chest pain—Etoposide—sarcoma	0.00177	0.0022	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—sarcoma	0.00176	0.00219	CcSEcCtD
Sodium stibogluconate—Fatigue—Mitoxantrone—sarcoma	0.00176	0.00219	CcSEcCtD
Sodium stibogluconate—Constipation—Mitoxantrone—sarcoma	0.00174	0.00217	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Thiotepa—sarcoma	0.00174	0.00216	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Dactinomycin—sarcoma	0.00173	0.00215	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Vincristine—sarcoma	0.00171	0.00213	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Etoposide—sarcoma	0.0017	0.00211	CcSEcCtD
Sodium stibogluconate—Asthenia—Thiotepa—sarcoma	0.00169	0.00211	CcSEcCtD
Sodium stibogluconate—Infection—Etoposide—sarcoma	0.00169	0.0021	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—sarcoma	0.00168	0.00209	CcSEcCtD
Sodium stibogluconate—Asthenia—Dactinomycin—sarcoma	0.00168	0.00209	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—sarcoma	0.00168	0.00209	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—sarcoma	0.00167	0.00208	CcSEcCtD
Sodium stibogluconate—Pruritus—Thiotepa—sarcoma	0.00167	0.00208	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00167	0.00207	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—sarcoma	0.00167	0.00207	CcSEcCtD
Sodium stibogluconate—Tachycardia—Etoposide—sarcoma	0.00166	0.00206	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Vincristine—sarcoma	0.00166	0.00206	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Vincristine—sarcoma	0.00166	0.00206	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Etoposide—sarcoma	0.00164	0.00204	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—sarcoma	0.00163	0.00203	CcSEcCtD
Sodium stibogluconate—Urticaria—Mitoxantrone—sarcoma	0.00162	0.00202	CcSEcCtD
Sodium stibogluconate—Anorexia—Etoposide—sarcoma	0.00162	0.00201	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Thiotepa—sarcoma	0.00162	0.00201	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Mitoxantrone—sarcoma	0.00161	0.00201	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Mitoxantrone—sarcoma	0.00161	0.00201	CcSEcCtD
Sodium stibogluconate—Bronchitis—Epirubicin—sarcoma	0.00161	0.002	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Dactinomycin—sarcoma	0.0016	0.002	CcSEcCtD
Sodium stibogluconate—Hypotension—Etoposide—sarcoma	0.00159	0.00197	CcSEcCtD
Sodium stibogluconate—Dizziness—Thiotepa—sarcoma	0.00156	0.00194	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—sarcoma	0.00156	0.00194	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—sarcoma	0.00155	0.00192	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Vincristine—sarcoma	0.00154	0.00192	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Etoposide—sarcoma	0.00152	0.0019	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Etoposide—sarcoma	0.00151	0.00188	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Mitoxantrone—sarcoma	0.0015	0.00187	CcSEcCtD
Sodium stibogluconate—Asthenia—Vincristine—sarcoma	0.0015	0.00187	CcSEcCtD
Sodium stibogluconate—Vomiting—Thiotepa—sarcoma	0.0015	0.00187	CcSEcCtD
Sodium stibogluconate—Vomiting—Dactinomycin—sarcoma	0.00149	0.00185	CcSEcCtD
Sodium stibogluconate—Rash—Thiotepa—sarcoma	0.00149	0.00185	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—sarcoma	0.00149	0.00185	CcSEcCtD
Sodium stibogluconate—Dermatitis—Thiotepa—sarcoma	0.00149	0.00185	CcSEcCtD
Sodium stibogluconate—Headache—Thiotepa—sarcoma	0.00148	0.00184	CcSEcCtD
Sodium stibogluconate—Rash—Dactinomycin—sarcoma	0.00148	0.00184	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Etoposide—sarcoma	0.00147	0.00183	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—sarcoma	0.00147	0.00182	CcSEcCtD
Sodium stibogluconate—Asthenia—Mitoxantrone—sarcoma	0.00146	0.00182	CcSEcCtD
Sodium stibogluconate—Fatigue—Etoposide—sarcoma	0.00146	0.00182	CcSEcCtD
Sodium stibogluconate—Constipation—Etoposide—sarcoma	0.00145	0.0018	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vincristine—sarcoma	0.00143	0.00178	CcSEcCtD
Sodium stibogluconate—Nausea—Thiotepa—sarcoma	0.0014	0.00175	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Mitoxantrone—sarcoma	0.0014	0.00174	CcSEcCtD
Sodium stibogluconate—Nausea—Dactinomycin—sarcoma	0.00139	0.00173	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Etoposide—sarcoma	0.00139	0.00173	CcSEcCtD
Sodium stibogluconate—Dizziness—Vincristine—sarcoma	0.00139	0.00172	CcSEcCtD
Sodium stibogluconate—Renal failure—Doxorubicin—sarcoma	0.00136	0.00169	CcSEcCtD
Sodium stibogluconate—Urticaria—Etoposide—sarcoma	0.00135	0.00168	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Etoposide—sarcoma	0.00134	0.00167	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Etoposide—sarcoma	0.00134	0.00167	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—sarcoma	0.00133	0.00166	CcSEcCtD
Sodium stibogluconate—Vomiting—Vincristine—sarcoma	0.00133	0.00166	CcSEcCtD
Sodium stibogluconate—Rash—Vincristine—sarcoma	0.00132	0.00164	CcSEcCtD
Sodium stibogluconate—Dermatitis—Vincristine—sarcoma	0.00132	0.00164	CcSEcCtD
Sodium stibogluconate—Headache—Vincristine—sarcoma	0.00131	0.00163	CcSEcCtD
Sodium stibogluconate—Vomiting—Mitoxantrone—sarcoma	0.0013	0.00161	CcSEcCtD
Sodium stibogluconate—Rash—Mitoxantrone—sarcoma	0.00129	0.0016	CcSEcCtD
Sodium stibogluconate—Dermatitis—Mitoxantrone—sarcoma	0.00128	0.0016	CcSEcCtD
Sodium stibogluconate—Headache—Mitoxantrone—sarcoma	0.00128	0.00159	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Etoposide—sarcoma	0.00125	0.00155	CcSEcCtD
Sodium stibogluconate—Nausea—Vincristine—sarcoma	0.00124	0.00155	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—sarcoma	0.00123	0.00153	CcSEcCtD
Sodium stibogluconate—Asthenia—Etoposide—sarcoma	0.00122	0.00151	CcSEcCtD
Sodium stibogluconate—Nausea—Mitoxantrone—sarcoma	0.00121	0.00151	CcSEcCtD
Sodium stibogluconate—Pruritus—Etoposide—sarcoma	0.0012	0.00149	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—sarcoma	0.0012	0.00149	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Etoposide—sarcoma	0.00116	0.00144	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—sarcoma	0.00115	0.00143	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—sarcoma	0.00114	0.00142	CcSEcCtD
Sodium stibogluconate—Dizziness—Etoposide—sarcoma	0.00112	0.0014	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—sarcoma	0.00111	0.00138	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—sarcoma	0.0011	0.00137	CcSEcCtD
Sodium stibogluconate—Vomiting—Etoposide—sarcoma	0.00108	0.00134	CcSEcCtD
Sodium stibogluconate—Rash—Etoposide—sarcoma	0.00107	0.00133	CcSEcCtD
Sodium stibogluconate—Dermatitis—Etoposide—sarcoma	0.00107	0.00133	CcSEcCtD
Sodium stibogluconate—Headache—Etoposide—sarcoma	0.00106	0.00132	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—sarcoma	0.00106	0.00132	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—sarcoma	0.00106	0.00131	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—sarcoma	0.00105	0.0013	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—sarcoma	0.00103	0.00128	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—sarcoma	0.00102	0.00127	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—sarcoma	0.00102	0.00126	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—sarcoma	0.00101	0.00126	CcSEcCtD
Sodium stibogluconate—Nausea—Etoposide—sarcoma	0.00101	0.00125	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—sarcoma	0.000992	0.00123	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—sarcoma	0.000989	0.00123	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—sarcoma	0.000967	0.0012	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—sarcoma	0.000953	0.00119	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—sarcoma	0.000951	0.00118	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—sarcoma	0.000951	0.00118	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—sarcoma	0.000948	0.00118	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—sarcoma	0.000945	0.00118	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—sarcoma	0.000936	0.00116	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—sarcoma	0.000934	0.00116	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—sarcoma	0.000928	0.00115	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—sarcoma	0.000919	0.00114	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—sarcoma	0.000918	0.00114	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—sarcoma	0.000915	0.00114	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—sarcoma	0.000907	0.00113	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—sarcoma	0.000889	0.00111	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—sarcoma	0.00088	0.00109	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—sarcoma	0.00088	0.00109	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—sarcoma	0.000874	0.00109	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—sarcoma	0.000866	0.00108	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—sarcoma	0.000859	0.00107	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—sarcoma	0.000854	0.00106	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—sarcoma	0.000851	0.00106	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—sarcoma	0.000848	0.00105	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—sarcoma	0.000839	0.00104	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—sarcoma	0.000827	0.00103	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—sarcoma	0.000822	0.00102	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—sarcoma	0.00082	0.00102	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—sarcoma	0.000813	0.00101	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—sarcoma	0.00079	0.000983	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—sarcoma	0.000785	0.000976	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—sarcoma	0.000778	0.000967	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—sarcoma	0.000765	0.000952	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—sarcoma	0.000759	0.000944	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—sarcoma	0.000756	0.00094	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—sarcoma	0.000753	0.000936	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—sarcoma	0.000752	0.000935	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—sarcoma	0.000752	0.000935	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—sarcoma	0.00072	0.000895	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—sarcoma	0.000701	0.000872	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—sarcoma	0.000699	0.00087	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—sarcoma	0.000696	0.000865	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—sarcoma	0.000696	0.000865	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—sarcoma	0.000682	0.000849	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—sarcoma	0.000673	0.000837	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—sarcoma	0.000651	0.000809	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—sarcoma	0.000648	0.000806	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—sarcoma	0.000631	0.000785	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—sarcoma	0.000629	0.000782	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—sarcoma	0.000623	0.000774	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—sarcoma	0.000605	0.000752	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—sarcoma	0.000602	0.000749	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—sarcoma	0.0006	0.000746	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—sarcoma	0.000599	0.000745	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—sarcoma	0.000596	0.000741	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—sarcoma	0.000582	0.000724	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—sarcoma	0.000565	0.000703	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—sarcoma	0.00056	0.000696	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—sarcoma	0.000555	0.00069	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—sarcoma	0.000554	0.00069	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—sarcoma	0.000551	0.000686	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—sarcoma	0.000523	0.00065	CcSEcCtD
